{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:29:09Z","timestamp":1780446549624,"version":"3.54.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.ijcard.2018.04.068","type":"journal-article","created":{"date-parts":[[2018,7,21]],"date-time":"2018-07-21T08:39:23Z","timestamp":1532162363000},"page":"195-199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Non-achievement of LDL-cholesterol targets in patients with diabetes at very-high cardiovascular risk receiving statin treatment: Incidence and risk factors"],"prefix":"10.1016","volume":"268","author":[{"given":"Cyril","family":"Breuker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Clement","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6420-1336","authenticated-orcid":false,"given":"Thibault","family":"Mura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1323-301X","authenticated-orcid":false,"given":"Val\u00e9rie","family":"Macioce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Castet-Nicolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohan","family":"Audurier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Boegner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Morcrette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Jalabert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Villiet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Avignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"Sultan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"40","key":"10.1016\/j.ijcard.2018.04.068_bb0005","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1093\/eurheartj\/ehv428","article-title":"Cardiovascular disease in Europe\u2014epidemiological update 2015","volume":"36","author":"Townsend","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2018.04.068_bb0010","author":"American Heart Association"},{"issue":"12","key":"10.1016\/j.ijcard.2018.04.068_bb0015","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/jama.2016.13985","article-title":"Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis","volume":"316","author":"Silverman","year":"2016","journal-title":"JAMA"},{"issue":"10059","key":"10.1016\/j.ijcard.2018.04.068_bb0020","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/S0140-6736(16)31357-5","article-title":"Interpretation of the evidence for the efficacy and safety of statin therapy","volume":"388","author":"Collins","year":"2016","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.ijcard.2018.04.068_bb0025","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/eurheartj\/ehx566","article-title":"Effect of statins and non-statin LDL-lowering medications on cardiovascular outcomes in secondary prevention: a meta-analysis of randomized trials","volume":"39","author":"Koskinas","year":"2017","journal-title":"Eur. Heart J."},{"issue":"9607","key":"10.1016\/j.ijcard.2018.04.068_bb0030","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(08)60104-X","article-title":"Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis","volume":"371","author":"Cholesterol Treatment Trialists C","year":"2008","journal-title":"Lancet"},{"issue":"39","key":"10.1016\/j.ijcard.2018.04.068_bb0035","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","article-title":"ESC\/EAS guidelines for the management of dyslipidaemias","volume":"37","author":"Catapano","year":"2016","journal-title":"Eur. Heart J."},{"issue":"Suppl. 2","key":"10.1016\/j.ijcard.2018.04.068_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP171764.APPGL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease","volume":"23","author":"Jellinger","year":"2017","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.ijcard.2018.04.068_bb0045","series-title":"Managing Dyslipidemia in the Context of Diabetes","first-page":"100","volume":"vol. 2","author":"Kirby","year":"2017"},{"key":"10.1016\/j.ijcard.2018.04.068_bb0050","series-title":"Principales dyslipid\u00e9mies: strat\u00e9gies de prise en charge","author":"Haute Autorit\u00e9 de Sant\u00e9","year":"2017"},{"key":"10.1016\/j.ijcard.2018.04.068_bb0055","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.atherosclerosis.2017.08.013","article-title":"Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: results from the dyslipidemia international study II","volume":"266","author":"Gitt","year":"2017","journal-title":"Atherosclerosis"},{"issue":"Suppl. 1","key":"10.1016\/j.ijcard.2018.04.068_bb0060","article-title":"Microvascular complications and foot care: standards of medical care in diabetes-2018","volume":"41","author":"American Diabetes A. 10","year":"2018","journal-title":"Diabetes Care"},{"issue":"14","key":"10.1016\/j.ijcard.2018.04.068_bb0065","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","article-title":"ESC\/EAS guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"32","author":"European Association for Cardiovascular P, Rehabilitation","year":"2011","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.ijcard.2018.04.068_bb0070","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.acvd.2012.11.003","article-title":"Attainment of low-density lipoprotein cholesterol target in the French general population according to levels of cardiovascular risk: insights from the MONA LISA study","volume":"106","author":"Bongard","year":"2013","journal-title":"Arch. Cardiovasc. Dis."},{"key":"10.1016\/j.ijcard.2018.04.068_bb0075","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12933-015-0296-y","article-title":"Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology","volume":"14","author":"Gyberg","year":"2015","journal-title":"Cardiovasc. Diabetol."},{"issue":"4","key":"10.1016\/j.ijcard.2018.04.068_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.gheart.2015.11.003","article-title":"Time trends in lifestyle, risk factor control, and use of evidence-based medications in patients with coronary heart disease in Europe: results from 3 EUROASPIRE Surveys, 1999\u20132013","volume":"12","author":"Kotseva","year":"2017","journal-title":"Glob. Heart"},{"issue":"6","key":"10.1016\/j.ijcard.2018.04.068_bb0085","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.diabet.2016.07.033","article-title":"Consensus statement on the management of dyslipidaemias in adults","volume":"42","author":"French Society of Endocrinology, Francophone Society of Diabetes, New French Society of Atherosclerosis","year":"2016","journal-title":"Diabete Metab."},{"key":"10.1016\/j.ijcard.2018.04.068_bb0090","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ijcard.2016.02.015","article-title":"The gender gap in risk factor control: effects of age and education on the control of cardiovascular risk factors in male and female coronary patients. The EUROASPIRE IV study by the European Society of Cardiology","volume":"209","author":"De Smedt","year":"2016","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2018.04.068_bb0095","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.pcad.2016.07.008","article-title":"The role of lipid treatment in women in primary prevention","volume":"59","author":"Gulati","year":"2016","journal-title":"Prog. Cardiovasc. Dis."},{"issue":"11","key":"10.1016\/j.ijcard.2018.04.068_bb0100","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11883-016-0619-9","article-title":"Statin adherence: does gender matter?","volume":"18","author":"Goldstein","year":"2016","journal-title":"Curr Atheroscler Rep"},{"issue":"1","key":"10.1016\/j.ijcard.2018.04.068_bb0105","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.amjcard.2015.10.007","article-title":"Comparison of adherence to guideline-based cholesterol treatment goals in men versus women","volume":"117","author":"Schoen","year":"2016","journal-title":"Am. J. Cardiol."},{"issue":"11","key":"10.1016\/j.ijcard.2018.04.068_bb0110","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0195-668X(03)00114-3","article-title":"Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project","volume":"24","author":"Conroy","year":"2003","journal-title":"Eur. Heart J."},{"issue":"9","key":"10.1016\/j.ijcard.2018.04.068_bb0115","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.2337\/dc12-1759","article-title":"Quality of care of people with type 2 diabetes in eight European countries: findings from the Guideline Adherence to Enhance Care (GUIDANCE) study","volume":"36","author":"Stone","year":"2013","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.ijcard.2018.04.068_bb0120","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pcad.2016.07.011","article-title":"Nonstatins and proprotein convertase subtilisin\/kexin type 9 (PCSK9) inhibitors: role in non-familial hypercholesterolemia","volume":"59","author":"Robinson","year":"2016","journal-title":"Prog. Cardiovasc. Dis."},{"issue":"3","key":"10.1016\/j.ijcard.2018.04.068_bb0125","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1177\/1741826711407705","article-title":"Survey of physicians' practices in the control of cardiovascular risk factors: the EURIKA study","volume":"19","author":"Dallongeville","year":"2012","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"12","key":"10.1016\/j.ijcard.2018.04.068_bb0130","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.2337\/dc12-0369","article-title":"Pharmacist interventions to improve cardiovascular disease risk factors in diabetes: a systematic review and meta-analysis of randomized controlled trials","volume":"35","author":"Santschi","year":"2012","journal-title":"Diabetes Care"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318316139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318316139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,4]],"date-time":"2018-08-04T08:29:35Z","timestamp":1533371375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527318316139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":26,"alternative-id":["S0167527318316139"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.04.068","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-achievement of LDL-cholesterol targets in patients with diabetes at very-high cardiovascular risk receiving statin treatment: Incidence and risk factors","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.04.068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}